Company Filing History:
2 out of 9,152 
1 out of 1 Years Active: 2013-2018
Title: Innovations of Jin-Shuen Chen
Introduction
Jin-Shuen Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of protein fragments related to various health conditions. With a total of 3 patents, his work has the potential to impact the diagnosis and treatment of diseases.
Latest Patents
One of his latest patents is a method of detecting a urine protein fragment and a serum protein fragment. This method describes the detection of a protein fragment in both urine and serum samples obtained from the same individual. The protein fragments identified include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, and serum osteopontin fragments. Another significant patent focuses on urine and serum biomarkers associated with diabetic nephropathy. This patent discloses the use of these biomarkers for diagnosing, staging, monitoring, and assessing the efficacy of treatments for diabetic nephropathy. The biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.
Career Highlights
Jin-Shuen Chen has worked with prominent organizations such as the Industrial Technology Research Institute and Bio Preventive Medicine Corporation. His experience in these institutions has allowed him to develop innovative solutions in the medical field.
Collaborations
Throughout his career, Jin-Shuen Chen has collaborated with talented individuals, including Wei-Ya Lin and Mary Ya-Ping Yeh. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Jin-Shuen Chen's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving healthcare. His work in detecting protein fragments and biomarkers is paving the way for better diagnosis and treatment options.